Dance classes for breast cancer survivors with neuropathy
Official title: Novel Interventions for Chemotherapy-Induced Neuropathy
Run by Ohio State University Comprehensive Cancer Center · NCT05114005 · Data updated 2026-05-14
This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.
This study is testing whether Argentine Tango dance classes can help breast cancer survivors with neuropathy feel better and improve their balance compared to doing exercises at home.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 40 Years and up |
| Sex | All |
| Enrollment | 52 (estimated) |
| Sponsor | Ohio State University Comprehensive Cancer Center Academic / other |
| Drugs / interventions | chemotherapy, immunotherapy |
| Locations | 1 site (Columbus, Ohio) |
| Trial ID | NCT05114005 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are breast cancer survivors who have completed taxane-based chemotherapy at least 3 months prior and are experiencing neuropathy symptoms.
✕Probably not a fit
Patients with pre-existing vestibular deficits or those who are non-ambulatory may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the effects of Argentine Tango dance classes compared to home exercise on postural control and neuropathy symptoms in breast cancer survivors. Participants will be randomly assigned to either the dance intervention or a control group, with assessments of balance, gait variability, and quality of life conducted throughout the study. The aim is to determine if dance can improve physical and psychosocial health outcomes in this population. Data will be collected on various health metrics, including falls incidence and patient-reported outcomes.
Why it matters
Potential benefit: If successful, this intervention could enhance the quality of life and physical health of breast cancer survivors suffering from neuropathy.
How similar studies have gone: While dance interventions have shown promise in other rehabilitation contexts, this specific approach for breast cancer survivors with neuropathy is novel and has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Breast cancer survivor stage I-III * Symptomatic for neuropathy * postural control outside 70% CI for adults who are middle-aged without neurotrauma * having completed taxane-based chemotherapy treatment at least 3 months ago; * able to understand and comply with directions associated with testing and study treatments. Exclusion Criteria: * Pre-existing vestibular deficit; * poorly controlled diabetes (hgA1C \> 8); * non-ambulatory or lower extremity amputation (assistive devices allowed); * use of cytotoxic or immunotherapy during study (endocrine therapy allowed); * participation in physical therapy during the study; * contraindication to participate in Tango due to orthopedic issue (e.g., herniated vertebral disc);
Where it's running
-
Stephanie Spielman Comprehensive Breast Center
Columbus, Ohio, United States Recruiting
Study contacts
- Principal investigator: Lise Worthen-Chaudhari, PhD, MFA — Ohio State University Comprehensive Cancer Center
- Study coordinator: Lise C Worthen-Chaudhari, PhD, MFA
- Email: lise.worthen-chaudhari@osumc.edu
- Phone: 614-293-6281
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Home-use Erchonia EVRL laser for temporary relief of idiopathic peripheral neuropathy foot pain
This study will test whether a home-use Erchonia EVRL laser can provide temporary relief of foot pain for adults with idiopathic peripheral neuropathy.
-
Collecting clinical, nerve conduction, electromyography, and ultrasound data in adults with peripheral neuropathy
This project will see if collecting detailed clinical, nerve conduction, electromyography, and ultrasound data from adults with peripheral neuropathy during routine visits can improve understanding and care.
-
Blood microRNA markers for chemotherapy-related peripheral nerve damage in lung and colorectal cancer
This study will test whether levels of tiny blood molecules called microRNAs can predict how often and how badly patients with lung or colorectal cancer get nerve damage from certain chemotherapies.
-
Nerve effects of enfortumab vedotin in people with urothelial cancer
We will see how nerve testing and patient-reported symptoms change in adults with urothelial cancer who are starting enfortumab vedotin.
-
Transcutaneous pulsed radiofrequency for postherpetic neuralgia pain
This study will try a non-invasive pulsed radiofrequency treatment applied through the skin to reduce pain in adults with postherpetic neuralgia who have not responded to standard treatments.
-
Feasibility of paired non-invasive blood flow and tissue oxygen monitoring to detect limb ischemia during lithotomy-position surgeries
This study tests whether using combined non-invasive blood flow monitoring and tissue oxygen sensors during long lithotomy surgeries can help detect early limb ischemia in adults.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.